Position in ZLAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,938,567
+$35,211,097 QoQ
Shares Held
2,207,293
+1011.9% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#7
of 92 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ZLAB ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in ZLAB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,938,567 | 2,207,293 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $6,727,470 | 198,509 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $41,999,529 | 1,201,016 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $43,404,718 | 1,201,016 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $46,089,083 | 1,759,797 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $38,816,202 | 1,607,962 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $40,425,413 | 2,332,684 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,601,312 | 2,596,836 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $55,166,342 | 2,018,527 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,481,888 | 801,394 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,184,677 | 223,032 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,207,489 | 336,966 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,084,402 | 198,189 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,845,851 | 463,329 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,447,046 | 647,262 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,820,917 | 291,517 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $7,025,297 | 66,660 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,054,592 | 85,059 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,527,893 | 78,902 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,305,815 | 61,370 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||